>INGN – The more cynical question is why file [a BLA], knowing they only had a sixty day window before a go/no go decision from the FDA?<
1. It provides an opportunity to raise capital.
2. Against all odds, it might work (like a Hail Mary pass from your own 10-yard line in football).
3. In the extremely likely event of an RTF letter, the company can claim that the FDA is at fault and request a hearing, perpetuating the whole process while the executives continue to earn fat salaries and bonuses.
--
A better way to look at this is to ask what would happen if the company announced it would not submit a BLA?
Market Data 
Markets 
AI
